![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
A more recent version of this article appeared on February 1, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on June 24, 2002
Revised on October 14, 2002
Accepted on October 28, 2002
during BMP2-induced Adipogenesis
1 Department of Biochemistry, and Department of Removable Prothodontics, Osaka University Graduate School, Faculty of Dentistry
2 Department of Biochemistry, Osaka University Graduate School, Faculty of Dentistry
3 Department of Removable Prothodontics, Osaka University Graduate School, Faculty of Dentistry
* Corresponding author. E-mail address: rikonisi{at}dent.osaka-u.ac.jp.
Bone morphogenetic protein 2 (BMP2) promotes the differentiation of undifferentiated mesenchymal cells into adipocytes. To investigate the molecular mechanisms that regulate this differentiation process, we studied the relationship between BMP2 signaling and PPAR
during adipogenesis of mesenchymal cells using pluripotent mesenchymal cell line C3H10T1/2. In C3H10T1/2 cells, BMP2 induced expression of PPAR along with adipogenesis. Overexpression of Smad6, a natural antagonist for Smad1, blocked PPAR expression and adipocytic differentiation induced by BMP2. Overexpression of dominant-negative PPAR also diminished adipocytic differentiation of C3H10T1/2 cells, suggesting the central role of PPAR in BMP2-induced adipocytic differentiation. Specific inhibitors for p38 kinase inhibited BMP2-induced adipocytic differentiation and transcriptional activation of whereas overexpression of Smad6 had no effect on transcriptional activity of PPAR. Furthermore, activation of p38 kinase by overexpression of TAK1 and TAB1, without affecting PPAR expression, led the up-regulation of transcriptional activity of PPAR. These results suggest that both Smad and p38 kinase signaling are concomitantly activated and responsible for BMP2-induced adipocytic differentiation by inducing and up-regulating PPAR, respectively. Thus, BMP2 controls adipocytic differentiation by utilizing two distinct signaling pathways that play differential roles in this process in C3H10T1/2 cells.
This article has been cited by other articles:
|
|
 |
|
  K. Amano, F. Ichida, A. Sugita, K. Hata, M. Wada, Y. Takigawa, M. Nakanishi, M. Kogo, R. Nishimura, and T. Yoneda Msx2 Stimulates Chondrocyte Maturation by Controlling Ihh Expression J. Biol. Chem., October 24, 2008; 283(43): 29513 - 29521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. McGuigan, E. Larzenius, M. Callreus, P. Gerdhem, H. Luthman, and K. Akesson Variation in the bone morphogenetic protein-2 gene: effects on fat and lean body mass in young and elderly women Eur. J. Endocrinol., May 1, 2008; 158(5): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ptasinska, S. Wang, J. Zhang, R. A. Wesley, and R. L. Danner Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway FASEB J, March 1, 2007; 21(3): 950 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pache, C. Schafer, S. Wiesemann, E. Springer, M. Liebau, H. C. Reinhardt, C. August, H. Pavenstadt, and M. J. Bek Upregulation of Id-1 via BMP-2 receptors induces reactive oxygen species in podocytes Am J Physiol Renal Physiol, September 1, 2006; 291(3): F654 - F662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ikeda, R. Nishimura, T. Matsubara, K. Hata, S. V. Reddy, and T. Yoneda Activation of NFAT Signal In Vivo Leads to Osteopenia Associated with Increased Osteoclastogenesis and Bone-Resorbing Activity J. Immunol., August 15, 2006; 177(4): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gao, Q. He, B. Peng, P. J. Chiao, and J. Ye Regulation of Nuclear Translocation of HDAC3 by I{kappa}B{alpha} Is Required for Tumor Necrosis Factor Inhibition of Peroxisome Proliferator-activated Receptor {gamma} Function J. Biol. Chem., February 17, 2006; 281(7): 4540 - 4547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aouadi, K. Laurent, M. Prot, Y. Le Marchand-Brustel, B. Binetruy, and F. Bost Inhibition of p38MAPK Increases Adipogenesis From Embryonic to Adult Stages Diabetes, February 1, 2006; 55(2): 281 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Schaiff, I. Bildirici, M. Cheong, P. L. Chern, D. M. Nelson, and Y. Sadovsky Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Signaling Regulate Fatty Acid Uptake by Primary Human Placental Trophoblasts J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4267 - 4275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Burgess, L. E. Daugherty, T. H. Thatcher, H. F. Lakatos, D. M. Ray, M. Redonnet, R. P. Phipps, and P. J. Sime PPAR{gamma} agonists inhibit TGF-{beta} induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1146 - L1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ichida, R. Nishimura, K. Hata, T. Matsubara, F. Ikeda, K. Hisada, H. Yatani, X. Cao, T. Komori, A. Yamaguchi, et al. Reciprocal Roles of Msx2 in Regulation of Osteoblast and Adipocyte Differentiation J. Biol. Chem., August 6, 2004; 279(32): 34015 - 34022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Hu, D. Wasserman, S. Hartwig, and N. D. Rosenblum p38MAPK Acts in the BMP7-dependent Stimulatory Pathway during Epithelial Cell Morphogenesis and Is Regulated by Smad1 J. Biol. Chem., March 26, 2004; 279(13): 12051 - 12059. [Abstract] [Full Text] [PDF]
|
|
